Use of endobronchial one-way valves reveals questions on etiology of spontaneous pneumothorax: report of three cases by Yu, Wai Cho et al.
BioMed  Central
Page 1 of 4
(page number not for citation purposes)
Journal of Cardiothoracic Surgery
Open Access Case report
Use of endobronchial one-way valves reveals questions on etiology 
of spontaneous pneumothorax: report of three cases
Wai Cho Yu*1, Yiu Cheong Yeung1, Yiu Chang1, Yuet Ling Tsang2, 
Kwok Chu Kwong1, Hau Chung Kwok1 and YC Gary Lee3
Address: 1Department of Medicine & Geriatrics, Princess Margaret Hospital, Hong Kong, 2Central Endoscopy Unit, Princess Margaret Hospital 
Hong Kong, Hong Kong and 3University of Western Australia & Lung Institute of Western Australia, Sir Charles Gairdner Hospital, Perth, Australia
Email: Wai Cho Yu* - yuwc@ha.org.hk; Yiu Cheong Yeung - yeungyc@ha.org.hk; Yiu Chang - changy@ha.org.hk; 
Yuet Ling Tsang - tsangyl@pmh.ha.org.hk; Kwok Chu Kwong - kwongkc@ha.org.hk; Hau Chung Kwok - khc054@ha.org.hk; YC 
Gary Lee - gary.lee@uwa.edu.au
* Corresponding author    
Abstract
Spontaneous pneumothoraces are believed to arise when air from the supplying airway exit via a
ruptured visceral pleural bleb into the pleural cavity. Endobronchial one-way valves (EBVs) allow
air exit (but not entry) from individual segmental airways. Systematic deployment of EBVs was
applied to three patients with secondary spontaneous pneumothoraces and persistent airleak. In
all cases, balloon-catheter occlusion of the upper lobe bronchus stopped the airleak. EBVs applied
to individual upper lobe segmental airways failed to terminate the airleak, which only stopped after
placements of multiple EBVs to occlude all upper lobe segments. The observation questions the
traditional belief of 'one-airway-one-bleb-one-leak' in spontaneous pneumothorax.
Introduction
Secondary spontaneous pneumothoraces are common in
clinical practice[1,2]. Pneumothorax is conventionally
believed to result from rupture of a bleb on the visceral
pleura, through which air of the supplying airway drains
into the pleural cavity.
Recent data have questioned this concept. Blebs are com-
mon findings on CT of both healthy subjects and patients
with lung diseases - most with no consequences. Noppen
et al have shown that aerosolized flourescin diffusely
accumulated along the visceral pleura in pneumothorax
patients, and postulated that air leaks diffusely through
micro-pores (pleural porosity theory) in the visceral
pleura[3].
Advances on endobronchial one-way valves (EBVs) pro-
vide a unique opportunity to add insight to this debate.
EBVs allow air exit (but not entry) from the segmental
bronchi in which the valve is deployed. EBVs would theo-
retically be ideal for treating pneumothoraces, if they are
results of airleak from one bleb and its supplying airway.
Pooled series however showed immediate success rates of
only 48%[4].
We describe the use of EBV in three patients with second-
ary pneumothoraces in which systematic placements of
EBVs in different airway subsegments revealed findings
that question the traditional 'one-airway-one-bleb-one-
leak' concept.
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Patients
All three patients were Chinese males with heavy smoking
history and high-resolution CT evidence of diffuse
emphysematous changes (including bullae), and pre-
sented with a spontaneous pneumothorax with persistent
airleak. All had very limited respiratory functions, and
high operative and anesthetic risks. Non-surgical options
with EBV placements were attempted. Written informed
consent was obtained from the patients for publication of
this report and any accompanying images.
Case 1
A 73 year-old presented with dyspnea and a near-com-
plete left pneumothorax (fig 1a). Thoracostomy brought
satisfactory lung expansion, but airleak persisted. During
fibreoptic bronchoscopy (day 23), balloon-catheter occlu-
sion of the left upper lobe (LUL) bronchus (but not indi-
vidual LUL segments or left lower lobe bronchus) resulted
in immediate cessation of bubbling via the chest-tube.
Placement of an EBV (Emphasys, CA, USA) to occlude
LB4+LB5 failed to arrest the airleak; nor did a second EBV
placed in LB3, and a third in LB1. Repositioning the LB3
valve into LB2 made no impact, but the addition of a
fourth EBV in LB3 (thus occluding all LUL segments)
immediately stopped the airleak (fig 2). The patient was
discharged two days later. Post-insertion radiograph
showed incomplete re-expansion of the LUL (fig 1b)
which fully resolved eventually after removal of EBVs.
Case 2
A 61-year old with COPD and bronchiectasis had a right
pneumothorax treated with bedside pleurodesis 10 years
ago. He re-presented with an 80% right pneumothorax
with apical adhesions which partially re-expanded with
chest-tube drainage, but airleak continued. During bron-
choscopy (day 34), the airleak stopped instantly with bal-
loon-catheter occlusion of the right upper lobe (RUL)
bronchus, but not the individual lobar subsegments or
the bronchus intermedius. EBVs were therefore placed in
RB1, RB2 and RB3. When all three devices were deployed
the airleak promptly stopped - though it resumed but at a
much reduced rate after 30 minutes and eventually settled
completely within 72 hours. He re-presented with exacer-
bations of COPD twice in the subsequent six weeks but no
further pneumothoraces.
(a, upper) CT scan of patient #1 prior to EBV insertion showing extensive emphysematous changes and bullae in the underlying  lung, a large left pneumothorax and the inserted chest tube Figure 1
(a, upper) CT scan of patient #1 prior to EBV insertion showing extensive emphysematous changes and bullae 
in the underlying lung, a large left pneumothorax and the inserted chest tube. (b, lower) The airleak via the chest 
drain stopped immediately after EBV placements to occlude all upper lobe segments. The drain was removed. CXR on day 3 
post-EBV insertion showed an incomplete expansion (but not total collapse) of the left upper lobe, which eventually re-
expanded after bronchoscopic removal of the EBVs six weeks afterwards.Journal of Cardiothoracic Surgery 2009, 4:63 http://www.cardiothoracicsurgery.org/content/4/1/63
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Case 3
A 70-year old man presented with chest pain and a 50%
right pneumothorax which re-expanded after chest-tube
insertion, but airleak persisted. At bronchoscopy (day 23),
balloon-catheter occlusion of the RUL bronchus or bron-
chus intermedius failed to stop the airleak. Insertion of an
EBV in RB1+2 and another in RB3 were technically diffi-
cult and required a second bronchoscopy the next day to
achieve optimal placements. No immediate slowing of
the airleak was observed, which persisted for a further 11
days before it spontaneously resolved. Follow-up CXR
showed incomplete re-expansion of RUL with no pneu-
mothorax.
None of the patients had recurrence of pneumothoraces
after eight months of follow-up. All EBVs were unevent-
fully removed bronchoscopically six to ten weeks after
insertion.
Discussions and Conclusion
The incidence of spontaneous pneumothorax, especially
from emphysema, is rising and its etiology remains con-
troversial.
Our findings question the conventional concept that, in
spontaneous pneumothorax, air leaks from a single sup-
plying airway through a ruptured bleb on the visceral
pleura. Systematic occlusion of any single segmental air-
way failed to terminate airleak in all three patients
described. A retrospective series also showed multiple
valves (mean 3.2/patient) were needed in secondary
pneumothorax from COPD (n = 12 patients) and, despite
that, immediate success was achieved only in 48%[4].
This helps explain the high recurrence rates (~20%) in
pneumothorax patients treated with bleb resection
alone[2].
Several hypotheses may explain these findings. Endo-
bronchial lung volume reduction studies have suggested
that collateral ventilation, or even alveolar-alveolar anas-
tomoses, is underestimated[5]. Airflow through these
channels increases markedly in diffuse emphysema[6].
This may explain the need of occlusion of most adjacent
airways in the same lobe to arrest airleaks in patients (#1
and #2), and may also explain the failures of EBVs as
occlusion of all collaterals is difficult.
Patients with pneumothorax had more significant and
generalized visceral pleural abnormalities than normal
subjects under autofluorescence thoracoscopy[3]. Inhaled
fluorescin in these patients spread over the visceral surface
rather than concentrate around one bleb[3]. Anatomical
studies have raised the possibility of visceral pleural pores
(of several microns wide); such porosity can account for
diffuse leakage (and thus the flourescin finding and our
observations).
Alternatively, there may be more than one bleb ruptured
in most patients. Modern imaging techniques reveal mul-
tiple blebs as common incidental findings. It is logical
that the yet unidentified trigger(s) of bleb rupture can
simultaneously affect most blebs, causing leaks from mul-
tiple sites.
Establishing the etiology of secondary pneumothoraces
has clinical implications: Strategies, eg pleurodesis, which
treat airleak from a diffuse visceral origin are more appro-
priate than localized therapy (eg bleb resection). It may
aid identification of suitable candidates for EBVs in future.
No suitable animal models exist and future elucidation
relies on collaborative clinical studies using endobron-
chial and imaging techniques. Whether findings on the
etiology of secondary pneumothorax can be extrapolated
to primary ones also requires investigation.
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Bronchoscopic view of the upper lobe bronchus in patient #1  showing EBVs inserted at each of the three upper lobe seg- ments (top) and the lingular segments (bottom) Figure 2
Bronchoscopic view of the upper lobe bronchus in 
patient #1 showing EBVs inserted at each of the 
three upper lobe segments (top) and the lingular seg-
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